Pictet Asset Management (UK)’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$1.44M Buy
79,138
+33,738
+74% +$601K ﹤0.01% 1053
2021
Q1
$788K Sell
45,400
-2,300
-5% -$40.4K ﹤0.01% 1094
2020
Q4
$829K Sell
47,700
-8,600
-15% -$137K ﹤0.01% 1052
2020
Q3
$776K Buy
56,300
+15,800
+39% +$232K ﹤0.01% 999
2020
Q2
$584K Sell
40,500
-17,100
-30% -$225K ﹤0.01% 956
2020
Q1
$629K Buy
57,600
+15,700
+37% +$290K ﹤0.01% 975
2019
Q4
$894K Buy
41,900
+5,700
+16% +$128K ﹤0.01% 994
2019
Q3
$831K Buy
36,200
+2,600
+8% +$55.5K ﹤0.01% 933
2019
Q2
$662K Buy
33,600
+4,200
+14% +$81.8K ﹤0.01% 940
2019
Q1
$572K Buy
29,400
+7,000
+31% +$133K ﹤0.01% 937
2018
Q4
$369 Buy
+22,400
New +$451K ﹤0.01% 925

Other funds holding SBRA

Pictet Asset Management (UK)'s SBRA Position: Q2 2021 in Review

Pictet Asset Management (UK) increased its Sabra Healthcare REIT (SBRA) stake by 74% in Q2 2021, buying an estimated $601K and bringing the position to 79,138 shares worth $1.44M. The position accounts for ﹤0.01% of the portfolio, ranked #1053.

Pictet Asset Management (UK) first reported a position in SBRA in Q4 2018 and has held it in 11 quarters since. 318 funds tracked by Wall St. Rank hold SBRA as of Q2 2021.

  • Pictet Asset Management (UK) held 79,138 shares of Sabra Healthcare REIT worth $1.44M as of Q2 2021.
  • Pictet Asset Management (UK) bought 33,738 Sabra Healthcare REIT shares in Q2 2021, an estimated $601K.
  • Sabra Healthcare REIT made up ﹤0.01% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #1053 holding.
  • Pictet Asset Management (UK) first reported a position in Sabra Healthcare REIT in Q4 2018 and has held it in 11 quarters since.
  • 318 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.